← Open Payments lookup

LAURYN SAENZ: Open Payments

NPI 1710669643 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,068 in 121 payments from 22 companies in 2025. Trend: 2023 $702 · 2024 $2,476 · 2025 $2,068

Food & beverage: $2,068
CompanyPaymentsAmount
Novo Nordisk Inc19$438
ABBVIE INC.19$316
Lilly USA, LLC11$250
Amgen Inc.23$174
AstraZeneca Pharmaceuticals LP6$146
Bayer Healthcare Pharmaceuticals Inc.6$107
Dexcom, Inc.4$90
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$90
GlaxoSmithKline, LLC.5$79
Otsuka America Pharmaceutical, Inc.4$62

Products named: Ozempic, MOUNJARO, VRAYLAR, Wegovy, OTEZLA, AIRSUPRA, Kerendia, Dexcom G6 Transmitter.

Industry payments across TX — which companies pay providers there.